jay – Axial Biotherapeutics

Federico Bolognani, M.D., PH.D.

Dr. Bolognani joins Axial Therapeutics with over 20 years of experience in translational neuroscience research in academia, pharmaceutical and the biotechnology industries. Most recently, [...]

Axial Biotherapeutics Appoints Federico Bolognani, M.D., Ph.D., Vice President and Head of Clinical Science

September 22, 2020

Axial Biotherapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

September, 15, 2020

Axial Biotherapeutics to Present at The JMP Securities CNS Forum

August 12, 2020

Axial Biotherapeutics Announces a Research Grant Award from The Michael J. Fox Foundation for the Development of an Enteric Nervous System Model to Assess Novel Parkinson’s Disease Therapeutics

July 28, 2020

Axial Biotherapeutics to Present at the Jefferies Virtual Global Healthcare Conference

May 27, 2020

Axial Biotherapeutics to Present Virtual Presentation at American Society of Clinical Psychopharmacology (ASCP) 2020 Annual Meeting

May 22, 2020

Axial Biotherapeutics Announces Positive Topline Results from Phase 1b/2a Clinical Trial of AB-2004 for the Treatment of Autism Spectrum Disorder

April 02, 2020

Axial Biotherapeutics to Present at the Chardan 2nd Annual Microbiome Medicines Virtual Summit

March 10, 2020

Chris Meyer

Chris has more than 20 years of biopharma development experience, with an emphasis on program management, CMC, and process development. He has built and led teams both in the US and Europe that [...]